Drug Report History #94397
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v8-EN | Version v6-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-10-10 (Updated) | 2019-10-09 |
| Drug Identification Number | 02270404 | 02270404 |
| Brand name | GONAL-F PEN | GONAL-F PEN |
| Common or Proper name | Follitropin alfa | Follitropin alfa |
| Company Name | EMD SERONO A DIVISION OF EMD INC CANADA | EMD SERONO A DIVISION OF EMD INC CANADA |
| Ingredients | FOLLITROPIN ALFA | FOLLITROPIN ALFA |
| Strength(s) | 300UNIT | 300UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | SUBCUTANEOUS | SUBCUTANEOUS |
| Packaging size | 1 pre-filled pen / stylo prérempli | 1 pre-filled pen / stylo prérempli |
| ATC code | G03GA | G03GA |
| ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2019-10-01 | 2019-10-01 |
| Actual start date | ||
| Estimated end date | 2019-10-18 | 2019-10-18 |
| Actual end date | 2019-10-09 | 2019-10-09 |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Other formats of GONAL-f are still available, please contact EMD Serono Customer Care for any questions at 1-800-387-9749. | Other formats of GONAL-f are still available, please contact EMD Serono Customer Care for any questions at 1-800-387-9749. |
| Health Canada comments |